These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12766702)

  • 1. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 2. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
    Sheehan DV; Sheehan KH; Raj BA
    Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam (Xanax, and others) revisited.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):5-7. PubMed ID: 15647704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alprazolam treatment for panic disorder.
    Miller F
    J Clin Psychiatry; 1987 Jul; 48(7):301. PubMed ID: 3597336
    [No Abstract]   [Full Text] [Related]  

  • 5. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to "high anxiety".
    Piper A
    J Clin Psychopharmacol; 1994 Aug; 14(4):290-2. PubMed ID: 7962695
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
    Fukuda M; Takazawa S; Nakagome K; Iwanami A; Hata A; Kasai K; Hiramatsu K
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 12. Alprazolam for panic disorder.
    Med Lett Drugs Ther; 1991 Apr; 33(841):30-1. PubMed ID: 2002784
    [No Abstract]   [Full Text] [Related]  

  • 13. Discontinuation of alprazolam after long-term treatment of panic-related disorders.
    DuPont RL; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Rubin RT; Rifkin A; Pecknold JC
    J Clin Psychopharmacol; 1992 Oct; 12(5):352-4. PubMed ID: 1479053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine, alprazolam withdrawal, and panic disorder.
    Lawlor BA
    Am J Psychiatry; 1987 Feb; 144(2):265-6. PubMed ID: 3812814
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of long-term alprazolam users in the community.
    Romach MK; Somer GR; Sobell LC; Sobell MB; Kaplan HL; Sellers EM
    J Clin Psychopharmacol; 1992 Oct; 12(5):316-21. PubMed ID: 1479048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
    Glue P; Fang A; Gandelman K; Klee B
    Am J Ther; 2006; 13(5):418-22. PubMed ID: 16988537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder.
    Shioiri T; Kita N; Takahashi S
    Int Clin Psychopharmacol; 1996 Jun; 11(2):149-52. PubMed ID: 8803653
    [No Abstract]   [Full Text] [Related]  

  • 18. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of alprazolam in the therapy of panic disorders].
    Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.